Arrowhead Pharmaceuticals Inc Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh(BR:A2RR34)
R$31.620.00 (0.00%)
BR:A2RR34
Arrowhead Pharmaceuticals Inc Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh earnings date
R$31.62
At close:0.00 (0.00%)
Arrowhead Pharmaceuticals Inc Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (A2RR34) Q2 2024 Earnings Report
BR:A2RR34 Q2 2024 EPS Results
- Actual EPS
- BRL 0.00
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- BRL 0.00
BR:A2RR34 Q2 2024 Revenue Results
- Actual Revenue
- BRL 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -100.00%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 05/09/2024
- Time
- After Close
- Conference Call
- Thursday, May 9, 2024
BR:A2RR34 Upcoming Earnings
Arrowhead Pharmaceuticals Inc Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh's next earnings date is estimated for February 10, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
BR:A2RR34 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 10, 2027 | 2027 (Q1) | ―- | 0 | ― | ― |
| Nov 12, 2026 | 2026 (Q4) | ―-0.00 | 0 | ― | |
| Aug 04, 2026 | 2026 (Q3) | ―-0.00 | 0 | 0.00% (+0.00) | |
| May 07, 2026 | 2026 (Q2) | ―-0.00 | 0 | -150.00% (-0.00) | |
| Feb 05, 2026 | 2026 (Q1) | ―0.00 | 0 | 100.00% (+0.00) | |
| Nov 25, 2025 | 2025 (Q4) | ―0.00 | 0 | 100.00% (+0.00) | |
| Aug 07, 2025 | 2025 (Q3) | ―-0.00 | 0 | 0.00% (+0.00) | |
| May 12, 2025 | 2025 (Q2) | ―0.00 | 0 | 300.00% (+0.00) | |
| Feb 10, 2025 | 2025 (Q1) | ―-0.00 | 0 | 0.00% (+0.00) | |
| Nov 26, 2024 | 2024 (Q4) | ―-0.00 | 0 | 0.00% (+0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

